InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by SCHADE CHRISTIAN S, Chairman & CEO. Officer active across 2 companies, notably Integra Lifesciences Holdings CORP. In total, 7 filings have been logged. Total volume traded: €23k. The latest transaction was disclosed on 3 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€49,24665,770 shares@ €0.74880.83% mcap46.5% of flow
Common Stock
SEC:0001104659-22-069015:0·
€23,03537,500 shares@ €0.61430.39% mcap21.7% of flow
Common Stock
SEC:0001104659-22-062916:0·
Ideal exit: 12 Feb 2023 (T+270)
01,265 shares0
Common Stock
SEC:0001209191-22-029707:0·
0100,100 shares0
Common Stock
SEC:0001104659-22-033393:0·
€33,65321,644 shares@ €1.55490.56% mcap31.8% of flow
Common Stock
SEC:0001104659-22-028767:0·
0530 shares0
Common Stock
SEC:0001209191-21-033148·
0530 shares0
Common Stock
SEC:0001209191-21-033148:0·
7 of 7 declarations
About SCHADE CHRISTIAN S
Christian S. Schade is a Director and Chairman & CEO at INTEGRA LIFESCIENCES HOLDINGS CORP and Aprea Therapeutics, Inc. His leadership is essential for the strategic direction of the companies.
